These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6364456)
21. In vitro metabolism of N-nitrosopyrrolidine by rat lung subcellular fractions: alpha-hydroxylation in a non-target tissue. Hecker LI Chem Biol Interact; 1980 Apr; 30(1):57-65. PubMed ID: 7379205 [TBL] [Abstract][Full Text] [Related]
22. Metabolism of the liver carcinogen N-nitrosopyrrolidine by rat liver microsomes. Hecker LI; Farrelly JG; Smith JH; Saavedra JE; Lyon PA Cancer Res; 1979 Jul; 39(7 Pt 1):2679-86. PubMed ID: 445471 [TBL] [Abstract][Full Text] [Related]
23. Alpha-hydroxylation and mutagenicity of unsymmetrical N-nitrosodialkylamines with a butyl group. Suzuki E; Mochizuki M; Takeda K; Okada M Jpn J Cancer Res; 1985 Mar; 76(3):184-91. PubMed ID: 3922836 [TBL] [Abstract][Full Text] [Related]
24. The effect of pyrazole, phenobarbital, ethanol and 3-methylcholanthrene pretreatment on the in vivo and in vitro genotoxicity of N-nitrosopyrrolidine. Gold B; Brunk G Carcinogenesis; 1988 Jun; 9(6):1001-5. PubMed ID: 3286025 [TBL] [Abstract][Full Text] [Related]
25. N-nitrosamines: bacterial mutagenesis and in vitro metabolism. Guttenplan JB Mutat Res; 1987 Sep; 186(2):81-134. PubMed ID: 3306361 [TBL] [Abstract][Full Text] [Related]
26. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis. Degawa M; Kojima M; Hashimoto Y Mutat Res; 1985; 152(2-3):125-9. PubMed ID: 3934534 [TBL] [Abstract][Full Text] [Related]
27. Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine. Frantz CN; Malling HV Cancer Res; 1975 Sep; 35(9):2307-14. PubMed ID: 1097107 [TBL] [Abstract][Full Text] [Related]
28. Metabolism and mutagenicity of N-nitrosohexamethyleneimine and its hydroxylated derivatives. Hecker LI; Saavedra JE; Andrews AW Teratog Carcinog Mutagen; 1983; 3(1):9-17. PubMed ID: 6132461 [TBL] [Abstract][Full Text] [Related]
29. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity. Shah AB; Combes RD; Rowland IR Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546 [TBL] [Abstract][Full Text] [Related]
30. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium. Lijinsky W; Andrews AW Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832 [TBL] [Abstract][Full Text] [Related]
31. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay. Prival MJ; Mitchell VD Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474 [TBL] [Abstract][Full Text] [Related]
32. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722 [TBL] [Abstract][Full Text] [Related]
33. Mutagenicities of N-nitrosamines on Salmonella. Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555 [TBL] [Abstract][Full Text] [Related]
34. Alpha-hydroxylation of N-nitrosopyrrolidine and N'-nitrosonornicotine by human liver microsomes. Hecht SS; Chen CH; McCoy GD; Hoffmann D; Domellöf L Cancer Lett; 1979 Nov; 8(1):35-41. PubMed ID: 509417 [TBL] [Abstract][Full Text] [Related]
35. Reconstitution of rabbit liver microsomal N-nitrosopyrrolidine alpha-hydroxylase activity. McCoy GD; Koop DR Cancer Res; 1988 Jul; 48(14):3987-92. PubMed ID: 3383193 [TBL] [Abstract][Full Text] [Related]
36. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction. Mori Y; Yamazaki H; Toyoshi K; Denda A; Konishi Y Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116 [TBL] [Abstract][Full Text] [Related]
37. Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation. Braun R; Jäkel HP; Schöneich J Mutat Res; 1984; 137(2-3):61-9. PubMed ID: 6381996 [TBL] [Abstract][Full Text] [Related]
38. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests. Gatehouse D; Wedd DJ Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032 [TBL] [Abstract][Full Text] [Related]
39. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations. Yourtee DM; Kirk-Yourtee CL Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349 [TBL] [Abstract][Full Text] [Related]
40. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases. Lin DX; Malaveille C; Park SS; Gelboin HV; Bartsch H Carcinogenesis; 1990 Sep; 11(9):1653-8. PubMed ID: 2119260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]